Sequential administration of the peptide vaccine and CPI induced CD4+ and CD8+ T-cell responses specific to multiple peptides, including peptides 3–5 and Survivin, correlating with tumor regression and durable remission. The gene discussed is CD8A; the disease is neoplasm.